In today’s briefing:
- Kuaishou (1024 HK): FY2024 Result, Op Margin to 10% from 4%, Price to Be Double
- Shanghai Henlius Biotech (2696 HK) – Thoughts on 2024 Results And the H Share Full Circulation
- AbbVie Inc.: An Analysis Of Its Immunology Market Expansion, Oncology Pipeline & ADC Strategy!
- Oracle Is Quietly Dominating AI Cloud — 57% OCI Surge and a Game-Changing Data Platform!
- Kunlun Energy (135 HK): Remains Very Decent
- Accenture Just Crushed Earnings — But DOGE Could Be Its Worst Nightmare Yet!
- Sage Group (SGE LN): The AI Strategy Is Taking Shape
- Jabil Inc.: Will Its Growth In Intelligent Infrastructure and AI Growth Last Over The Coming Quarters?
- MPLX LP: An Insight Into Its Natural Gas and NGL Value Chain Expansion & Critical Growth Levers!
- Asia Real Estate Tracker (25-Mar-2025): Warburg Pincus JV acquires second Korean asset.
Kuaishou (1024 HK): FY2024 Result, Op Margin to 10% from 4%, Price to Be Double
- Kuaishou (KS)’ operating margin improved to 10% in 2024 versus 4% in 2023.
- Online marketing revenue increased by 20% and GMV increased by 17% in 2024.
- We conclude an upside of 104% for the next twelve months.
Shanghai Henlius Biotech (2696 HK) – Thoughts on 2024 Results And the H Share Full Circulation
- Henlius has made a profit for the second year in a row.However, some investors are not satisfied with the quality of net profit growth in 2024 due to concerns behind.
- The implementation of H Share Full Circulation has a positive impact on financing ability, shareholder returns, market valuation of Henlius.The next goal is to be included in HK Stock Connect
- Lin Lijun’s continuous increase in Henlius holdings is an important reason for shares surge after privatization failure.Lin may keep pushing up share price so as to exit at higher price.
AbbVie Inc.: An Analysis Of Its Immunology Market Expansion, Oncology Pipeline & ADC Strategy!
- AbbVie Inc. concluded 2024 with robust performance metrics, highlighted by a notable return to growth, despite significant challenges such as the $5 billion U.S. Humira sales erosion due to biosimilar competition.
- The company reported a total revenue of $56.3 billion, surpassing its initial guidance by over $2 billion, with adjusted earnings per share recorded at $10.12, which is $0.49 above their previously forecasted midpoint.
- On a segmented basis, AbbVie’s “ex-Humira” platform, consisting primarily of Skyrizi and Rinvoq, demonstrated substantial growth.
Oracle Is Quietly Dominating AI Cloud — 57% OCI Surge and a Game-Changing Data Platform!
- Oracle Corporation’s third quarter fiscal year 2025 earnings report indicated significant strategic advancements and robust financial performance, balanced by some challenges.
- On the positive side, the company reported a record $48 billion addition to its backlog, bringing the remaining performance obligations (RPO) to $130 billion, which represents a 63% increase year-over-year.
- This growth suggests strong demand for Oracle’s cloud services, which is a key positive indicator for future revenue streams.
Kunlun Energy (135 HK): Remains Very Decent
- Kunlun Energy (135 HK)‘s net profit grew 7.9% in 2H24, accelerating from 2.6% in 1H24. It is encouraging to see the dividend payout ratio increase by 2pp YoY.
- An increase in the adoption of the residential price linkage system is positive for the dollar margin, while the distortion from E&P expiry will no longer impact earnings.
- With net cash equals HK$2.56/share, or 31% of the share price, such financial strength is unmatched by peers. Its PER valuations are also inexpensive.
Accenture Just Crushed Earnings — But DOGE Could Be Its Worst Nightmare Yet!
- Accenture delivered better-than-expected results for the second quarter of fiscal 2025, but the stock took a steep hit as investor concerns mounted over potential fallout from U.S. federal cost-cutting initiatives.
- The consulting giant posted earnings of $2.82 per share, just above the analyst consensus of $2.81, and reported revenue of $16.7 billion, surpassing expectations of $16.6 billion and marking a 5% year-over-year increase.
- However, despite this beat, the company’s shares plunged 9.4% to $292.72, logging their worst single-day performance since June 2013 and becoming the S&P 500’s worst performer on the day.
Sage Group (SGE LN): The AI Strategy Is Taking Shape
- Sage launched its Copilot AI assistant automating accounting, HR and payroll tasks. This aims to roll out across all products by 2026. Sage plans to integrate AI agents into workflows.
- The Sage Network platform connects accounting systems across businesses, facilitating automated workflows and real-time data integration. It enhances Sage Copilot’s capabilities and creates opportunities for migration to cloud-based solutions.
- Sage’s resilient business model, supported by subscriptions, positions it well in a challenging market. The company is focused on expanding its customer base through AI-powered solutions.
Jabil Inc.: Will Its Growth In Intelligent Infrastructure and AI Growth Last Over The Coming Quarters?
- Jabil Inc. reported strong financial results for its second quarter of fiscal year 2025, delivering $6.7 billion in revenue and highlighting a year-on-year growth of 3% when adjusted for divestitures.
- Core operating income was reported at $334 million, with a core operating margin of 5%.
- On a GAAP basis, the company reported operating income of $245 million and diluted earnings per share of $1.06.
MPLX LP: An Insight Into Its Natural Gas and NGL Value Chain Expansion & Critical Growth Levers!
- MPLX, the midstream energy company, reported its fourth quarter and full-year 2024 results, highlighting strategic progress and robust financial performance.
- In 2024, MPLX achieved a full-year adjusted EBITDA of $6.8 billion, marking an 8% rise compared to the previous year, underpinned by strong operational performance across its renamed business segments: Crude Oil and Product Logistics and Natural Gas and NGL Services.
- This marks the fourth consecutive year of mid-single-digit adjusted EBITDA growth, with a compound annual growth rate of 7% since 2021.
Asia Real Estate Tracker (25-Mar-2025): Warburg Pincus JV acquires second Korean asset.
- Warburg Pincus and Wide Creek JV have acquired GreenFort, a Korean logistic asset, marking their second investment in the country.
- Gaw Capital is set to discuss a joint venture with MTD TV for the development of 1,200 homes in an upcoming interview on Wednesday.
- Mitsubishi Estate has sold its stake in a Shinjuku office tower to a J-REIT for $190 million, continuing its strategic real estate transactions.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
Unlock all research summaries